Minimally invasive treatment of long bone non‐unions with bone marrow concentrate, demineralized bone matrix and platelet‐rich fibrin in 38 patients
Journal of Tissue Engineering and Regenerative Medicine · 2021-10 · 15 (10) · 831-840
DOI: 10.1002/term.3231 ↗At a glance
Klinische Studie in Journal of Tissue Engineering and Regenerative Medicine, published online on 2021-08-05. Written by Luca Cevolani and 7 co-authors. Institution: Orthopaedic and Traumatologic Clinic Prevalently Oncologic, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy. Major MEDLINE topics: Bone Demineralization Technique. Cited 10 times so far (Crossref); 39 references.
Abstract (original language)
To determine the efficacy of percutaneous injection of autologous bone marrow concentrated (BMC), demineralized bone matrix (DBM), and platelet rich fibrin (PRF) in the treatment of long bone non-unions. From January 2011 to January 2018 patients with non-union of the lower limbs who were on the waiting list for open grafting with established tibial or femoral non-union and minimal deformity were eligible to participate in this study. Patients were treated with a single percutaneous injection of DBM, BMC and PRF. Our study group comprised 38 patients (26 males and 12 females; mean age 39, range 18 to 65). Non-unions were located in the femur (18 cases) and in the tibia (20 cases). Clinical and imaging follow-up ranged from 4 to 60 months (mean 20 months). Bone union occurred in 30 out of 38 patients (79%) in an average of 7 months (range 3 to 12) and all healed patients had full weight bearing after 9 months on average (range 6 to 12) from injection. In 19 cases the osteosynthesis was removed 12 months on average (range 3 to 36) from surgery. One patient developed infection at the non-union site after treatment. Percutaneous injection of DBM, BMC, and PRF is an effective treatment for long-bone non-unions. This technique allows the bone to heal with a minimally invasive approach and with a hospitalization of 2 days. Key elements of bone regeneration consist of a combination of biological and biomechanical therapeutic approach.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Orthopaedic and Traumatologic Clinic Prevalently Oncologic, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
- Unit of Orthopaedic Pathology and Osteoarticular Tissue Regeneration, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
ORCID profiles: Luca Cevolani
Cite
APA
Cevolani, L., Bianchi, G., Costantino, E., Staals, E., Lucarelli, E., Spazzoli, B., Frisoni, T., & Donati, D. M. (2021). Minimally invasive treatment of long bone non‐unions with bone marrow concentrate, demineralized bone matrix and platelet‐rich fibrin in 38 patients. Journal of Tissue Engineering and Regenerative Medicine, 15(10), 831-840. https://doi.org/10.1002/term.3231
Vancouver
Cevolani L, Bianchi G, Costantino E, Staals E, Lucarelli E, Spazzoli B, et al. Minimally invasive treatment of long bone non‐unions with bone marrow concentrate, demineralized bone matrix and platelet‐rich fibrin in 38 patients. Journal of Tissue Engineering and Regenerative Medicine. 2021;15(10):831-840. doi:10.1002/term.3231
BibTeX
@article{Cevolani2021,
author = {Cevolani, Luca and Bianchi, Giuseppe and Costantino, Errani and Staals, Eric and Lucarelli, Enrico and Spazzoli, Benedetta and Frisoni, Tommaso and Donati, Davide M},
title = {Minimally invasive treatment of long bone non‐unions with bone marrow concentrate, demineralized bone matrix and platelet‐rich fibrin in 38 patients},
journal = {Journal of Tissue Engineering and Regenerative Medicine},
year = {2021},
volume = {15},
number = {10},
pages = {831--840},
doi = {10.1002/term.3231}
}
EUVIMED